294 related articles for article (PubMed ID: 7533537)
1. Sites within the 39-kDa protein important for regulating ligand binding to the low-density lipoprotein receptor-related protein.
Warshawsky I; Bu G; Schwartz AL
Biochemistry; 1995 Mar; 34(10):3404-15. PubMed ID: 7533537
[TBL] [Abstract][Full Text] [Related]
2. Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein.
Warshawsky I; Bu G; Schwartz AL
J Biol Chem; 1993 Oct; 268(29):22046-54. PubMed ID: 7691821
[TBL] [Abstract][Full Text] [Related]
3. Binding analysis of amino-terminal and carboxyl-terminal regions of the 39-kDa protein to the low density lipoprotein receptor-related protein.
Warshawsky I; Bu G; Schwartz AL
J Biol Chem; 1994 Feb; 269(5):3325-30. PubMed ID: 7508911
[TBL] [Abstract][Full Text] [Related]
4. Analysis of ligand binding to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that lipoprotein lipase and the carboxyl-terminal domain of the receptor-associated protein bind to the same site.
Nielsen MS; Nykjaer A; Warshawsky I; Schwartz AL; Gliemann J
J Biol Chem; 1995 Oct; 270(40):23713-9. PubMed ID: 7559542
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding.
Horn IR; van den Berg BM; van der Meijden PZ; Pannekoek H; van Zonneveld AJ
J Biol Chem; 1997 May; 272(21):13608-13. PubMed ID: 9153209
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
Bu G; Maksymovitch EA; Schwartz AL
J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
Andersen OM; Petersen HH; Jacobsen C; Moestrup SK; Etzerodt M; Andreasen PA; Thøgersen HC
Biochem J; 2001 Jul; 357(Pt 1):289-96. PubMed ID: 11415462
[TBL] [Abstract][Full Text] [Related]
8. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.
Bu G; Williams S; Strickland DK; Schwartz AL
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7427-31. PubMed ID: 1502154
[TBL] [Abstract][Full Text] [Related]
9. The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties.
Neels JG; van Den Berg BM; Lookene A; Olivecrona G; Pannekoek H; van Zonneveld AJ
J Biol Chem; 1999 Oct; 274(44):31305-11. PubMed ID: 10531329
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells.
Iadonato SP; Bu G; Maksymovitch EA; Schwartz AL
Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):867-75. PubMed ID: 8280086
[TBL] [Abstract][Full Text] [Related]
11. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein.
Willnow TE; Orth K; Herz J
J Biol Chem; 1994 Jun; 269(22):15827-32. PubMed ID: 7515061
[TBL] [Abstract][Full Text] [Related]
12. Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone.
Obermoeller LM; Warshawsky I; Wardell MR; Bu G
J Biol Chem; 1997 Apr; 272(16):10761-8. PubMed ID: 9099728
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein.
Williams SE; Ashcom JD; Argraves WS; Strickland DK
J Biol Chem; 1992 May; 267(13):9035-40. PubMed ID: 1374383
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
Horn IR; Moestrup SK; van den Berg BM; Pannekoek H; Nielsen MS; van Zonneveld AJ
J Biol Chem; 1995 May; 270(20):11770-5. PubMed ID: 7538122
[TBL] [Abstract][Full Text] [Related]
15. Dissection of the domain architecture of the alpha2macroglobulin-receptor-associated protein.
Ellgaard L; Holtet TL; Nielsen PR; Etzerodt M; Gliemann J; Thøgersen HC
Eur J Biochem; 1997 Mar; 244(2):544-51. PubMed ID: 9119022
[TBL] [Abstract][Full Text] [Related]
16. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
Camani C; Gavin O; Bertossa C; Samatani E; Kruithof EK
Eur J Biochem; 1998 Feb; 251(3):804-11. PubMed ID: 9490055
[TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator.
Orth K; Willnow T; Herz J; Gething MJ; Sambrook J
J Biol Chem; 1994 Aug; 269(33):21117-22. PubMed ID: 8063731
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats.
Moestrup SK; Holtet TL; Etzerodt M; Thøgersen HC; Nykjaer A; Andreasen PA; Rasmussen HH; Sottrup-Jensen L; Gliemann J
J Biol Chem; 1993 Jun; 268(18):13691-6. PubMed ID: 7685767
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
